XML 46 R36.htm IDEA: XBRL DOCUMENT v3.24.3
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Nov. 30, 2023
Feb. 10, 2022
Feb. 15, 2019
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2020
Dec. 31, 2017
Sep. 30, 2023
Jan. 01, 2020
Product Information [Line Items]                  
Cash and cash equivalent       $ 31,316,461 $ 264,829        
Allowances for accounts receivable       175,640 121,987        
Bad debt expense       51,653 19,884        
Sales, marketing, and advertising costs       1,512,790 382,864        
Revenues       12,754,900 6,453,731        
Series B Preferred shares issued for acquisition valued at $1.41 per share       2,538,000          
Number of shares issued   96,778,105 2,967,000            
Shares issued price per share $ 1.41                
Number of shares acquired value         25,000        
Research and development expense       0 1,800        
Impairment charges       $ 0 $ 0        
Finite-lived intangible asset, useful life       3 years 3 years        
Amortization expense       $ 22,503 $ 159,051        
Amortized discount             $ 97,996    
Intrinsic value             $ 97,996    
Weighted average number of shares outstanding Basic       329,492,915 158,048,019        
Weighted average number of shares outstanding Diluted       329,492,915 158,048,019        
Intangible assets in fair value                 $ 2,644,842
Four Outstanding FRH Group Convertible Notes [Member]                  
Product Information [Line Items]                  
Potentially dilutive shares           20,000,000      
Alchemy Markets Ltd. [Member]                  
Product Information [Line Items]                  
Ownership pecentage 49.90%                
Series B Preferred Stock [Member]                  
Product Information [Line Items]                  
Series B Preferred shares issued for acquisition valued at $1.41 per share $ 2,533,334                
Conversion of shares 1,800,000                
Number of shares acquired value $ 2,538,000                
Series B Preferred Stock [Member] | Gope S. Kundnani [Member]                  
Product Information [Line Items]                  
Number of shares issued 1,800,000                
Number of shares acquired value $ 2,538,000                
Alchemy Prime Ltd [Member]                  
Product Information [Line Items]                  
Business acquisition, percentage of voting interests acquired 100.00%             100.00%  
Alchemy Prime Ltd [Member] | Series B Preferred Stock [Member]                  
Product Information [Line Items]                  
Number of shares acquired 966,379                
Series B Preferred shares issued for acquisition valued at $1.41 per share $ 1,362,594                
Alchemy Markets Ltd. [Member]                  
Product Information [Line Items]                  
Business acquisition, percentage of voting interests acquired 49.90%             49.90%  
Alchemy Markets Ltd. [Member] | Series B Preferred Stock [Member]                  
Product Information [Line Items]                  
Number of shares acquired 833,621                
Series B Preferred shares issued for acquisition valued at $1.41 per share $ 1,175,406                
Number of shares issued 1,800,000                
Alchemy Prime Holdings Ltd [Member]                  
Product Information [Line Items]                  
Number of shares issued 833,621                
Alchemy Prime Holdings Ltd [Member] | Gope S. Kundnani [Member]                  
Product Information [Line Items]                  
Business acquisition, percentage of voting interests acquired 100.00%       100.00%        
Series B Preferred shares issued for acquisition valued at $1.41 per share $ 2,538,000                
Revenue Benchmark [Member] | Sales and Marketing [Member] | Customer [Member]                  
Product Information [Line Items]                  
Concentration risk percentage       11.86% 5.93%        
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Top 3 Customers [Member]                  
Product Information [Line Items]                  
Concentration risk percentage       101.81% 101.81%        
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Top 3 Customers [Member]                  
Product Information [Line Items]                  
Concentration risk percentage       98.79% 82.99%